TissUse announces new partnership with leading pharmaceutical company to develop applications for its Multi-Organ-Chip platform in drug research and development

TissUse and Roche have signed a cooperating agreement to develop human-relevant in vitro assays based on TissUse’s Multi-Organ-Chip technology.


Apply now for the Grants4Apps Accelerator

Berlin is the new startup hub in Europe


TrueBrainConnect: predicting brain disorders

New ERC-funded project at Charité to combine EEG data and machine learning


Faster from the laboratory to the patient: Initiative of Fraunhofer, Helmholtz and Hochschulmedizin promotes pilot project in the health sector


In the development of new medications and medical engineering, there is a gap between the discovery of new potential active ingredients and products and their further development into medicinal products and medical devices by the industry. The...


HealthCapital Berlin-Brandenburg Receives the Silver Label from the European Secretariat for Cluster Analysis (ESCA)

European Clusters are audited as part of the European Cluster Excellence Initiative (ECEI), and receive excellence labels in one of three stages based on set benchmarks: bronze, silver, and gold. Over 950 Clusters in all industries have already...


LATEST INTERVIEW: Dr. Viola Bronsema, Managing Director, BIO Deutschland

Dr. Viola Bronsema has been Managing Director of Biotechnologie-Industrie-Organisation (BIO) Deutschland e.V. in Berlin since October 2006. Previously, the biologist was head of communications at Roche Diagnostics GmbH and Diagnostics EMEA in...


IMI2 - Call 14

Call ID:   H2020-JTI-IMI2-2018-14-two-stage
Action Type: RIA – Research and Innovation Actions


  • Topic 1: Targeted immune intervention for the management of non-response and relapse
  • Topic 2: Non-invasive clinical molecular imaging of...

Eckert & Ziegler Annual Financial Statement 2017: Profit and net liquidity reach new records, sales stable.


. Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in in isotope-related applications in medicine, science and industry, was able to push profits and net liquidity to new records in the 2017 fiscal...


Helicobacter creates immune system blind spot

By extracting cholesterol from host cell membranes, Helicobacter pylori generates “micro-islands”


NOXXON renegotiates ODIRNANE BSA financing agreement to remove unilateral option for investor to subscribe for tranches and to cancel existing warrants


NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), the “Company”, a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that it has renegotiated and signed an amendment to its...

Show more items